GTBP vs GILD: Which Stock is Better?
Side-by-side comparison of Gt Biopharma Inc and Gilead Sciences Inc in 2026
GTBP
Gt Biopharma Inc
$0.73
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | GTBP | GILD | Winner |
|---|---|---|---|
| Market Cap | $7.93M | $154.03B | GILD |
| P/E Ratio | N/A | 19.22 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.7% | GILD |
Analyze GTBP
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GTBP or GILD a better investment?
Comparing GTBP and GILD: Gt Biopharma Inc has a market cap of $7.93M while Gilead Sciences Inc has $154.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GTBP and GILD?
GTBP (Gt Biopharma Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GTBP or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GTBP or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for GTBP.
Which company is more profitable: GTBP or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for GTBP.
Which is the larger company: GTBP or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.03B compared to $7.93M for GTBP.
Should I buy GTBP or GILD in 2026?
Both GTBP and GILD have investment merit. GTBP trades at $0.73 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GTBP and GILD stock?
Key differences: Market Cap ($7.93M vs $154.03B), P/E Ratio (N/A vs 19.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).